Adrock, its interesting that I'm thinking about this very differently than you, at least for the epidural instrument. On that one they completed a study with very positive results, so it would seem to me that the FDA marketing clearance ought to be viewed as being pretty likely to be issued. But what good is a marketing clearance if you don't have a distributor lined up to market it. So that is why I believe the stock price should get a shot in the arm if & when they get a distributor for the epidural instrument.
Not sure I understand your comment about the intrarticular instrument. I thought they had previously announced that that instrument will in fact require additional testing.
Market Data 
Markets 
AI
